Advanced Practice Midwife in Wilmington, NC Accepting Medicare

8 Advanced Practice Midwife nurses found. Showing 1 - 8

Ms. Mary C Mcbride, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-772-9202    Fax: 910-772-9452

Pamela Ashlyn Irby, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2221 S 17th St, Wilmington, NC 28401 Phone: 910-815-5190    Fax: 910-815-0840

Susan Fowler Carney, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2221 S 17th St, Wilmington, NC 28401 Phone: 910-815-5190    Fax: 910-815-0840

Ashli Mckenzie Gibson, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 257 Shannon Dr, Wilmington, NC 28409 Phone: 704-219-0254

Laura R Schultz, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 925 N 4th St, Wilmington, NC 28401 Phone: 910-343-0270    Fax: 910-251-3450

Henna Shah Ables, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2221 S 17th St, Wilmington, NC 28401 Phone: 910-815-5190    Fax: 910-815-0840

Heather Jernigan Wilson, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1124 Gallery Park Ln, Wilmington, NC 28412 Phone: 910-343-1031    Fax: 910-251-8896

Cassie Jo Lohrey, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2221 S 17th St, Wilmington, NC 28401 Phone: 810-577-6498

News Archive

Population Diagnostics receives NINDS grant for identifying genetic causes of Parkinson's Disease

Population Diagnostics, Inc. ("PDx"), a private company with a novel approach to revealing the genetic causes of disease and predicting drug response, announced today it has been awarded a federal grant to identify the genetic causes of Parkinson's Disease. Funded by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health, the project is being led by Eli Hatchwell, MD, PhD, an Associate Professor at Stony Brook University Medical Center and a co-founder of PDx.

Forum for Collaborative HIV Research suggests new approach for conducting Phase 3 HIV clinical trials

As the war on HIV/AIDS begins its fourth decade, medical researchers, pharmaceutical manufacturers, patient advocates and government regulators face a new and unexpected scientific challenge: how to demonstrate the safety and efficacy of promising new antiretroviral drugs when the two traditional study designs – the superiority trial and the non-inferiority trial – are no longer useful in showing improvements in both "treatment experienced" patients and those who have never received drug therapy (treatment-naive patients).

Afinitor more than doubles progression-free survival in advanced pancreatic NET: Study

Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.

ADSC transplantation promotes adult neurogenesis in brains of Alzheimer's disease mice

Recent evidence has demonstrated that transplantation of mesenchymal stem cells can stimulate neurogenesis in the brain of adult rat or mouse models of Alzheimer's disease (AD) and improve tissue and function injury under the condition of cerebral ischemia.

Read more Medical News

› Verified 4 days ago